Menopause Completed Phase 4 Trials for Rosiglitazone (DB00412)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00440375Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenPrevention